Early adiposity rebound (child BMI curve)
BioMG follows French guidelines. Adapt it to the guidelines and the tests available where you practise.
Early rebound without overweight, normal height and examination: no tests, follow the curve
- The HAS guide provides for no laboratory test for an isolated early adiposity rebound, provided that the growth chart (no slowing), head circumference, clinical examination, eating behaviour and development have been checked. Any abnormality refers to the following tabs.
Early rebound with overweight or obesity: targeted tests
- Overweight with no clinical sign of complication and no indication for diabetes screening: no laboratory tests.
Fasting laboratory tests, depending on the context
- Fasting plasma glucose (screening for type 2 diabetes)if neededFrom age 10 or the onset of puberty, in overweight or obesity, with at least one risk factor: maternal or gestational diabetes, type 2 diabetes in a 1st- or 2nd-degree relative, signs or conditions of insulin resistance (acanthosis nigricans, hypertension, dyslipidaemia, PCOS, low birth weight for gestational age) [2]. Repeat at least every 3 years if normal [2]. If diabetes is confirmed, pancreatic tests must rule out autoimmune type 1 diabetes [2].
- Lipid profileif neededEstablished obesity (BMI ≥ IOTF 30 threshold) with a family history of dyslipidaemia [2].
- ASTif neededEstablished obesity (BMI ≥ IOTF 30 threshold), depending on family history, the trajectory of the BMI curve and the clinical history [2]. Recheck every 2 to 3 years if normal, especially in adolescence [2].
- ALTif neededEstablished obesity (BMI ≥ IOTF 30 threshold), depending on family history, the trajectory of the BMI curve and the clinical history [2]. Recheck every 2 to 3 years if normal, especially in adolescence [2].
Do not order
- Laboratory tests in a child who is simply overweight with no sign of complication and no indication for diabetes screening: no test is necessary [2].
- TSH, cortisol or other hormonal tests as a routine: the HAS limits the tests to targeted ones and does not include hormonal tests; it is the examination findings (slowing growth velocity, signs of thyroid dysfunction or hypercortisolism) that guide [2].
Obesity before age 6 with very early or absent rebound, or associated signs: consider a rare cause
- Headache, vomiting, visual disturbance, polyuria-polydipsia or drop in height: urgent hospital opinion and brain imaging.
- Specialist opinion (specialised obesity centre, PRADORT reference centre): do not wait for the tests before referring.
Tests to be organised with the centre consulted
- TSH (if rare cause suspected)if neededInitial assessment tests of the PNDS (French national protocol for diagnosis and care), to be coordinated with the centre consulted; hormone assays are guided by the clinical picture [4].
- Free T4 (if rare cause suspected)if neededInitial assessment tests of the PNDS (French national protocol for diagnosis and care), to be coordinated with the centre consulted; hormone assays are guided by the clinical picture [4].
- 8 am serum cortisol (if rare cause suspected)if neededInitial assessment tests of the PNDS (French national protocol for diagnosis and care), to be coordinated with the centre consulted; hormone assays are guided by the clinical picture [4].
- 8 am ACTH (if rare cause suspected)if neededInitial assessment tests of the PNDS (French national protocol for diagnosis and care), to be coordinated with the centre consulted; hormone assays are guided by the clinical picture [4].
- IGF-1 (if rare cause suspected)if neededInitial assessment tests of the PNDS (French national protocol for diagnosis and care), to be coordinated with the centre consulted; hormone assays are guided by the clinical picture [4].
- Fasting plasma glucose (if rare cause suspected)if neededInitial assessment tests of the PNDS, to be coordinated with the centre consulted; hormone assays are guided by the clinical picture [4]. In the young child, fasting is decided with the centre.
- Fasting insulin (if rare cause suspected)if neededInitial assessment tests of the PNDS, to be coordinated with the centre consulted; hormone assays are guided by the clinical picture [4]. In the young child, fasting is decided with the centre.
Also consider
Sources (13)
- Zhou J, Zhang F, Qin X, et al. Age at adiposity rebound and the relevance for obesity: a systematic review and meta-analysis. Int J Obes (Lond) 2022;46(8):1413-24.
- Haute Autorité de santé. Guide du parcours de soins : surpoids et obésité de l'enfant et de l'adolescent(e). Février 2022, mis à jour en février 2023 : chapitres 1.4, 1.7.4, 1.8, 2.2 et 2.3, annexes 5 et 6.
- Rolland-Cachera MF, Deheeger M, Maillot M, Bellisle F. Early adiposity rebound: causes and consequences for obesity in children and adults. Int J Obes (Lond) 2006;30 Suppl 4:S11-7.
- Centre de référence PRADORT. Protocole national de diagnostic et de soins : générique obésités de causes rares. Haute Autorité de santé, 19 juillet 2021 (texte du PNDS et synthèse à destination du médecin traitant).
- Rolland-Cachera MF, Deheeger M, Bellisle F, Sempé M, Guilloud-Bataille M, Patois E. Adiposity rebound in children: a simple indicator for predicting obesity. Am J Clin Nutr 1984;39(1):129-35.
- Whitaker RC, Pepe MS, Wright JA, Seidel KD, Dietz WH. Early adiposity rebound and the risk of adult obesity. Pediatrics 1998;101(3):E5.
- Eriksson JG, Forsén T, Tuomilehto J, Osmond C, Barker DJ. Early adiposity rebound in childhood and risk of Type 2 diabetes in adult life. Diabetologia 2003;46(2):190-4.
- Koyama S, Ichikawa G, Kojima M, Shimura N, Sairenchi T, Arisaka O. Adiposity rebound and the development of metabolic syndrome. Pediatrics 2014;133(1):e114-9.
- Freedman DS, Goodwin-Davies AJ, Kompaniyets L, et al. Interrelationships among age at adiposity rebound, BMI during childhood, and BMI after age 14 years in an electronic health record database. Obesity (Silver Spring) 2022;30(1):201-8.
- Freedman DS, Goodman AB, King RJ, Kompaniyets L, Daymont C. The relation of adiposity rebound to subsequent BMI in a large electronic health record database. Child Obes 2021;17(1):51-7.
- Rolland-Cachera MF, Bellisle F, Péneau S. BMI at age 3 years predicts later BMI but age at adiposity rebound conveys information on BMI pattern-health association. Obesity (Silver Spring) 2022;30(6):1133-4.
- Geserick M, Vogel M, Gausche R, et al. Acceleration of BMI in early childhood and risk of sustained obesity. N Engl J Med 2018;379(14):1303-12.
- Assurance maladie. Nomenclature des actes de biologie médicale (NABM), version 105 : acte 1577 (HbA1c).